mounjaro tirzepatide news for Weight Loss: Results, Side Effects and How It Works Weight-loss jab Mounjaro trial begins

Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 receptor agonist aimed at chronic weight management for adults living with obesity or excess weight combined with weight-related health conditions

If you work in a location where you could be exposed to zinc, be sure to disclose this to your healthcare professional

Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]

Another sirtuin, SIRT7, has been studied in relation to age-related mitochondrial stress

If you want help deciding whether a personalized program is right for you, complete the free assessment quiz to explore your options

Why the titration schedule exists The gradual dose escalation is not arbitrary